Successful Use of Lanadelumab in an Older Patient With Type II Hereditary Angioedema

Type II hereditary angioedema (HAE) is a rare, genetic disorder characterized by recurring subcutaneous and/or submucosal edema throughout the body and causes significant morbidity and mortality. Lanadelumab is a novel, long-term prophylactic treatment option for HAE and has proven to be an effectiv...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Federal Practitioner 2022-09, Vol.39 (9), p.390-392
Hauptverfasser:	Hellu, Maj Tasha, Weiss, Maj Samuel, Smith, Derek
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!